Global Conference Series Logo
Pharmaceutical conferences 2017 focus on Emarketing, eBusiness and eDetailing
(PRWEB) October 10, 2016
OMICS International pharmaceutical conferences explore next generation drug development, delivery, distribution, global pharma market analysis and the latest regulatory guidelines with the scholars, pharma medical representatives, business delegates, technologists and industrial leaders across the globe. Pharmaceutical conferences are intending to exchange knowledge related to pharma market analysis, large-scale manufacturing and insights on novel drug developments.
Pharma market research conferences cover a wide range of topics focused on recent advancements and challenges in the field. 2017 Pharmaceutical conferences plans to put forward global pharma market analysis, pharma brand management, pharma product management, pharma strategic planning, pharma business planning, pharma eMarketing, pharma eBusiness, pharma eDetailing, Drug discoveries, Pharma Drug Formulations, Bioavailability studies, Pharmacovigilance, Drug Designing and chemistry. OMICS International pharma meetings galvanize meaningful discussions as eminent researchers, business professionals and students take part in them. Pharma conferences create an exciting environment to explore the latest technologies and advances in the field. The Conference Series is also focused on events such as Regulatory Affairs, Pharmaceutical Analysis, Method Development and Validation, Pharma Market and latest research and development in the field of Biosimilars and Forensic Research.
The global pharmaceutical market is worth US$300 billion a year, a figure expected to rise to US$400 billion within three years. The 10 largest drug companies are controlling over one-third of this market, with sales of more than US$10 billion a year and a profit margins of about 30%.
Together with Canada, Mexico and the USA hold the largest continental Pharma market, in which 40% of the global pharmaceutical market is controlled by the US alone. Oncology, diabetes, and mental health care could attract maximum funding of US$90 billion in 2014. The pharmaceutical industry of the European Union is one of the most competitive sectors with substantial investments in research and development. It is a major source of growth and employment to the European economy. The market is set to grow from €169 billion in 2015 to €206 billion in 2022, exhibiting a CARG rate of 3.2% over the period. The Asian pharmaceutical market is gearing up to be at the center of the global market as 58% of the global pharmaceutical market is expected to emerge in Asia in the near future. Both India and Japan are expected to grow at rates of 11% and 8%, respectively, by 2019, and China is expected to record a near-12% increase. BMI's pharmaceutical expenditure forecasts show that, in general, developing countries will see a higher rate of pharmaceutical sales growth, while the growth for developed countries will be lower.
Based on the importance, scope and market analysis Conference Series accommodates 300+ International symposiums and workshops exclusively on Pharma based themes. Conference Series Pharmaceutical meetings are composed of Keynote lectures, plenary speeches, special scientific sessions, international symposiums, workshops, Exhibitions, and B2B Meetings. Innovative young researchers receive 'Young Scientist Awards' and Best Poster Awards for their contributions.
OMICS Group with its 2,000+ employees has been supported by 50,000+ well-qualified scientists as editorial board members who serve on voluntary basis to disseminate healthcare and scientific information open access, and year on year this support is increasing progressively with which OMICS Group is able to grow from 10 peer reviewed journals in 2009 to 700 peer reviewed journals by 2016. OMICS Group open access journals and conferences readers/online visitors also increased from 10,000 in 2009 to 30 million by 2016. OMICS International Conference Series organizes 3000 Scientific conferences every year across America, Europe, Middle East and Asia.